Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowAppendix 4C and Quarterly Activities Report - March 2026
Just nowSFG Quarterly Activities/Appendix 4CCash Flow Report
Just nowBSA Announces On-Market Share Buy-Back
1m agoPlacement
4m agoMarch 2026 Quarterly Activities & Cashflow Report

Maplight Therapeutics, Inc. Common Stock

About

Maplight Therapeutics, Inc. Common Stock (NASDAQ:MPLT) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 26 2026
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 2 2026
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Jan 9 2026
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Jan 5 2026
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Dec 16 2025
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies

Financials

Revenue
$0
Market Cap
$960.55 M
EPS
-18.56

Community Chat

Ask AI

6ix6ix